Page 4 - Real World Data News Today

Faculty offer expert insights into emerging data on BTK inhibitor resistance in CLL, referencing earlier findings that indicate the potential existence of mutations before BTK inhibitor exposure and the process of clonal selection.

The expert panel explores belumosudil's role in treating chronic GVHD after multiple systemic therapy lines. They discuss the ROCKstar trial, highlighting its overall response rates and real-world experiences.

Experts on mantle cell lymphoma discuss second-line treatment options available for patients.

Richard Furman, MD, outlines his strategy for addressing BTK inhibitor intolerance in CLL patients, underscoring the significance of BTK inhibitors in CLL treatment and advocating for transitioning to an alternative BTK inhibitor rather than completely discontinuing the class in cases of drug intolerance.

/PRNewswire/ -- ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Solutions and for healthcare and life sciences, today announced Jennifer...

MINNEAPOLIS, Jan. 29, 2024 -- OneMedNet Corporation , the leading curator of regulatory-grade imaging Real World Data , today announced its participation as an exhibitor at the 15th Annual SCOPE...

/PRNewswire/ -- The "Pharma Clinical Trial Services Market Report 2024-2034" report has been added to ResearchAndMarkets.coms offering. Pharma Clinical Trial...

Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.

Lynx.MD Builds Massive Gastroenterology (GI) Data Repository for Research ...

/PRNewswire/ -- LANGaware, an innovative leader in digital cognitive and behavioral health diagnostics, is announcing that it will partner with Premiers...